Skip to main content
OpenTrials
Completed

NCT Number: NCT02930577

Treatment Adherence in Substance Users

This study evaluates the factors associated with treatment adherence in substance users. Differences in the level of adherence to treatment according to patient-related factors, addiction and treatment are analyzed. The individual effect of each factor on treatment adherence is assessed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance-related Disorders Behavior Chemically-Induced Disorders Health Behavior Mental Disorders Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

INTRODUCTION: Treatment dropout is an unsolved problem in the addiction process which makes frequent the failure of the addiction therapy. Research shows that the majority of dropouts occur during the first weeks of the treatment. These are the most serious ones because they have the worst prognosis. Some factors, related to the patients and the therapy, have been associated with treatment dropout but the diversity of studied variables, the heterogeneity of patients and the sparse population of many studies, hampers external validity and comparison of results.

OBJECTIVES: Analyze the treatment adherence of an outpatient treatment program for addicts. Identify factors associated with treatment adherence in substance users.

MATERIAL AND METHODS: Observational, analytical, longitudinal and retrospective study in substance users who completed addiction treatment between November 2013 and January 2016. Treatment adherence is measured in terms of medical discharge, regular attendance at activities and success in the NOC indicators. Differences in the level of adherence to treatment according to patient-related factors, addiction and treatment are analyzed. The individual effect of each factor on treatment adherence is assessed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of Substance-Related Disorders
  • Treatment for drug dependency

Exclusion criteria

  • Admission for detoxification treatment.

Treatment and study plan

Primary outcomes

  1. treatment adherence

    Time frame: two month

    Good adherence: if the patient complete the treatment, attends health professionals sessions and/or gets a sufficient score in objectives nursing.

    Bad-adherence: if the patient not complete the treatment.

Secondary outcomes

  1. gender

    Time frame: two months

    options: male or female.

  2. age

    Time frame: two months

  3. work situation

    Time frame: two months

    options: unemployed, worker, pensioner or student.

  4. cohabitation

    Time frame: two months

    options: alone, with parents or with the couple and sons

  5. family support

    Time frame: two months

    options: no support, support, support and groups

  6. all mental disorders of DSM-IV (Diagnostic and Statistical Manual of mental Disorders)

    Time frame: two months

  7. all drugs

    Time frame: two months

  8. Self-esteem level according to the Rosenberg Self-Esteem questionnaire.

    Time frame: two months

    options: high, medium or low self-esteem level.

Sponsors and collaborators

Lead sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Other

Registry information

Official study title

Factors Associated With Treatment Adherence in Substance Users

Acronym: TASU

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Oct 12, 2016
Registry last updated
Oct 12, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.